EGFR mutation status and prognosis for gefitinib treatment in Japanese lung cancer

被引：16

作者：

Sasaki, H ^{[1
]}

Endo, K ^{[1
]}

Mizuno, K ^{[1
]}

Yano, M ^{[1
]}

Fukai, I ^{[1
]}

Yamakawa, Y ^{[1
]}

Fujii, Y ^{[1
]}

机构：

[1] Nagoya City Univ, Sch Med, Dept Surg 2, Nagoya, Aichi 4678601, Japan

来源：

LUNG CANCER | 2006年 / 51卷 / 01期

关键词：

D O I：

10.1016/j.lungcan.2005.09.004

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：135 / 136

页数：2

共 10 条

[1] Mutation in the tyrosine kinase domain of epidermal growth factor receptor is a predictive and prognostic factor for gefitinib treatment in patients with non-small cell lung cancer [J].

Chou, TY ;

Chiu, CH ;

Li, LH ;

Hsiao, CY ;

Tzen, CY ;

Chang, KT ;

Chen, YM ;

Perng, RP ;

Tsai, SF ;

Tsai, CM .

CLINICAL CANCER RESEARCH, 2005, 11 (10) :3750-3757

[2] Retrospective analysis of the predictive factors associated with the response and survival benefit of gefitinib in patients with advanced non-small-cell lung cancer [J].

Kaneda, H ;

Tamura, K ;

Kurata, T ;

Uejima, H ;

Nakagawa, K ;

Fukuoka, M .

LUNG CANCER, 2004, 46 (02) :247-254

[3] Predictors of the response to gefitinib in refractory non-small cell lung cancer [J].

Kim, KS ;

Jeong, JY ;

Kim, YC ;

Na, KJ ;

Kim, YH ;

Ahn, SJ ;

Baek, SM ;

Park, CS ;

Park, CM ;

Kim, YI ;

Lim, SC ;

Park, KO .

CLINICAL CANCER RESEARCH, 2005, 11 (06) :2244-2251

[4]

LYNCH TJ, 2004, NEW ENGL J MED, V53, P1192

[5] EGFR mutations in non-small-cell lung cancer:: Analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment [J].

Marchetti, A ;

Martella, C ;

Felicioni, L ;

Barassi, F ;

Salvatore, S ;

Chella, A ;

Camplese, PP ;

Iarussi, T ;

Mucilli, F ;

Mezzetti, A ;

Cuccurullo, F ;

Sacco, R ;

Buttitta, F .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (04) :857-865

[6] Mutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with non-small-cell lung cancer with postoperative recurrence [J].

Mitsudomi, T ;

Kosaka, T ;

Endoh, H ;

Horio, Y ;

Hida, T ;

Mori, S ;

Hatooka, S ;

Shinoda, M ;

Takahashi, T ;

Yatabe, Y .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (11) :2513-2520

[7]

PAEZ JG, 2004, SCIENCE, V81, P61

[8] EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib [J].

Pao, W ;

Miller, V ;

Zakowski, M ;

Doherty, J ;

Politi, K ;

Sarkaria, I ;

Singh, B ;

Heelan, R ;

Rusch, V ;

Fulton, L ;

Mardis, E ;

Kupfer, D ;

Wilson, R ;

Kris, M ;

Varmus, H .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (36) :13306-13311

[9]

ROSELL R, 2005, LUNG CANC 0709

[10] EGFR mutation status in Japanese lung cancer patients: Genotyping analysis using LightCycler [J].

Sasaki, H ;

Endo, K ;

Konishi, A ;

Takada, M ;

Kawahara, M ;

Iuchi, K ;

Matsumura, A ;

Okumura, M ;

Tanaka, H ;

Kawaguchi, T ;

Shimizu, T ;

Takeuchi, H ;

Yano, M ;

Fukai, I ;

Fujii, Y .

CLINICAL CANCER RESEARCH, 2005, 11 (08) :2924-2929

← 1 →